-
-
-
-
-
-
-
Merck shares rise on big Q2 earnings beat, adjusted FY outlook
-
-
-
-
-
-
-
FDA clears Merck's Keytruda combo for muscle-invasive bladder cancer
-
-
-
-
-
-
-
Merck Animal Health to acquire poultry technology firm TARGAN
-
-
-
-
-
-
-
Merck Highlights New Long-Term Data and Advancements Across Broad Oncology Portfolio and Pipeline Research at ASCO 2026
-
-
-
-
-
-
-
Merck & Co., Inc., Rahway, N.J., USA Announces First-Quarter 2026 Financial Results; Highlights Significant Regulatory Approvals and Clinical Milestones
-
-
-
-
-
-
-
Mizuho Downgrades Terns Pharmaceuticals (TERN) to Neutral on Merck acquisition
-
-
-
-
-
-
-
Truist Securities stays Buy on Terns Pharmaceuticals (TERN) as Merck acquires 'for a steal'
-
1,199,821 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


